#leerink
Latest news and interesting information about leerink.
Equillium SVP & COO sells $267,209 in shares
Equillium COO Christine Zedelmayer sells $267,209 in shares. Analysts optimistic about EQ504 drug pipeline.
Rocket Pharmaceuticals CEO sells $171,840 in stock
Rocket Pharmaceuticals CEO Gaurav Shah sells $171,840 worth of stock. Company shares down 52% over the past year.
Leerink Reaffirms Eli Lilly Stock Rating on Gene Therapy
Leerink reaffirms Eli Lilly stock rating with Outperform and $1,119 target, citing promising gene therapy data from VERVE-102 trial. Bond.az covers the latest.
...